Bloomfield, CT – Cigna Corporation (NYSE: CI) recently announced that Cigna shareholders have voted, at a special meeting of shareholders, to approve the adoption of the previously announced merger agreement with Express Scripts Holding Company (NASDAQ: ESRX), one of the nation’s leading pharmacy services companies.
According to the preliminary results announced at the meeting, approximately 90 percent of the votes cast were voted in favor of the merger agreement. The final voting results will be filed with the Securities and Exchange Commission on a Form 8-K.
“We are delighted that our fellow Cigna shareholders support our merger with Express Scripts in recognition of the combination’s significant value creation potential,” said David M. Cordani, President and Chief Executive Officer of Cigna. “Together with Express Scripts, Cigna will further accelerate our strategy of Go Deeper, Go Local and Go Beyond by improving affordability and choice, expanding our distribution reach, and further strengthening predictability for customers, clients, partners and communities – all while maintaining significant financial flexibility and delivering attractive returns for our shareholders.”
“Our combined company will enhance Cigna’s differentiated service-based model, fueled by actionable insights and analytics, to drive innovation and meaningful growth in a highly dynamic market environment. As a result, we will build more effective partnerships, further improve health outcomes and deliver a superior customer experience,” Cordani concluded.
Cigna anticipates that the merger will close by year-end 2018, subject to the satisfaction of customary closing conditions, including applicable regulatory approvals.